Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.

A breakthrough new treatment that is currently being tested successfully on rodents, promises tumour termination with one ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

TWO women lose their lives to cervical cancer every day in the UK. Like all types of the disease, the earlier it’s caught, the better. Around 95 per cent of those diagnosed at stage 1 will ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

With 90 to 95 per cent of cervical cancer cases caused by the human papillomavirus (HPV), vaccination offers a nearly 99 per cent protection rate against the disease. Prince Court Medical Centre ...

Get the scoop on this week’s hottest health topics! Dr. Iris Gorfinkel breaks down the latest egg recall due to salmonella, ...

Vaccines are helpful in protecting against the flu and COVID-19, but could they also play a role in the fight against cancer?

Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The ...

Chemoablation with mitomycin gel (Jelmyto) for low-grade upper tract urothelial cancer led to a 3-year recurrence-free ...

If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.

The Alabama Department of Public Health reports that there are 14,000 new HPV cases annually and 4,000 women die from the disease each year.